Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome.
MYO/DCI ratio
Polycystic ovary syndrome
inositol
Journal
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
ISSN: 1473-0766
Titre abrégé: Gynecol Endocrinol
Pays: England
ID NLM: 8807913
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
19
1
2024
Statut:
ppublish
Résumé
In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations.
Identifiants
pubmed: 38239032
doi: 10.1080/09513590.2023.2301554
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM